Loading
IDL Diagnostics Stock: price and insider trades · Sweden
No insider purchase over the last 90 days. The latest was filed 30 May 2026.
IDL Diagnostics: what insiders have been doing
Only a handful of insider records exist for IDL Diagnostics, the last one from 30 May 2026, too few to describe a trend. Every figure here comes from the filings published by Finansinspektionen and describes the past, not future prices; it is not investment advice.
Insider Decl.
1
Thresholds
n/a
Buy Volume
€8,862
1 ops. · all time
Sell Volume
n/a
n/a
Who traded when
BuySaleEva Nordström2 buys
Fundamental score
Ranked 21,156 of 24,148 companies
24.6
score / 100
Value15
Quality35
FCF yld-10%
Earn yld-14%
EV/EBITDA·
ROE-3.6%
Gross mgn52%
Net mgn-23%
Debt/EBITDA·
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Financial data
as of FY 2025FY ended December 2025 · cache
SEK 0.39
Analyst consensus
1 analysts0.00/5
SEK 1.00Target SEK 1.00(+158%)SEK 1.00
Income statement
RevenueSEK 53.1M
Gross profitSEK 27.7M52% margin
EBITDA-SEK 8.1M-15% margin
Net income-SEK 12.2M-7.5% margin
Valuation
P/Book0.6x
Beta0.94
Balance sheet & cash
Market capSEK 89.4M
Total debtSEK 13.2M
Free Cash Flow-SEK 9.2M
Debt / Equity8%
Profitability & ownership
ROE-3.6%
ROA-1.8%
% insiders31.1%
% institutions13.0%
Last declaration on 30 May 2026
Declarations1 total
200,000 shares@ SEK 0.48100.0% of flowAktieISIN SE0012193340FI:A003Z358-1
Canonical exit: 27 Aug 2026 (T+90)
1 of 1 declaration
About IDL Diagnostics
IDL Diagnostics is a company focused on developing medical diagnostic solutions. It operates on the XSTO stock market.
Recent ranked signals in the same sector
Purchases our model currently ranks for the recommendations list.
All recommendations
